-

SHAREHOLDER NEWS: Johnson Fistel Investigates Proposed Sale of Icosavax; Is the Deal in the Best Interest of Shareholders?

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Icosavax, Inc. (NASDAQ: ICVX) breached their fiduciary duties in connection with the proposed sale of the Company to AstraZeneca.

You can click or copy and paste the following link to join this investigation:

https://www.johnsonfistel.com/investigations/Icosavax-co

On November 30, 2023, Icosavax announced that it had entered a deal to merge with AstraZeneca. Under the terms of the deal, Icosavax shareholders will receive $15.00 per share in cash at closing, plus a non-tradable contingent value right to receive up to $5.00 in cash, payable upon achievement of specified regulatory and net sales milestones.

Nationally recognized Johnson Fistel is investigating whether the proposed deal represents adequate consideration, especially given a one Wall Street analyst has a $30.00 price target on the stock. If you are a shareholder of Icosavax and believe the proposed buyout price is too low or you're interested in learning more about the investigation, please contact lead analyst Jim Baker (jimb@johnsonfistel.com) at 619-814-4471. If emailing, please include a phone number.

About Johnson Fistel, LLP:

Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York, Georgia, and Colorado. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com.

Johnson Fistel, LLP is a shareholder rights law firm representing individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information, visit their website http://www.johnsonfistel.com.

Attorney advertising.

Past results do not guarantee future outcomes.

Services may be performed by attorneys in any of our offices.

Contacts

Johnson Fistel, LLP
501 W. Broadway, Suite 800, San Diego, CA 92101
James Baker, Investor Relations or Frank J. Johnson, Esq., (619) 814-4471
jimb@johnsonfistel.com or fjohnson@johnsonfistel.com

Industry:

Johnson Fistel, LLP

NASDAQ:ICVX
Release Versions
English

Contacts

Johnson Fistel, LLP
501 W. Broadway, Suite 800, San Diego, CA 92101
James Baker, Investor Relations or Frank J. Johnson, Esq., (619) 814-4471
jimb@johnsonfistel.com or fjohnson@johnsonfistel.com

More News From Johnson Fistel, LLP

MNTN, Inc. (MNTN) Investors Who Suffered Losses Encouraged to Contact Johnson Fistel Regarding Securities Investigation

SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP is investigating potential securities claims on behalf of MNTN, Inc. (NYSE: MNTN) investors following the stock's approximately 50% decline on November 5, 2026. The investigation concerns whether MNTN adequately disclosed the effects of changes to its sales organization on customer acquisition and revenue growth.What if I purchased MNTN securities?If you purchased MNTN securities and suffered losses, contact Johnson Fistel to learn more about the...

ServiceTitan (TTAN) Alert: Johnson Fistel Investigates Following Nearly 30% Stock Decline

SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP is investigating potential securities claims on behalf of ServiceTitan, Inc. (NASDAQ: TTAN) investors following the stock’s nearly 30% decline on September 9, 2026. The investigation concerns whether ServiceTitan adequately disclosed the financial effects of its Max AI rollout.What if I purchased ServiceTitan securities?If you purchased ServiceTitan securities and suffered losses, contact Johnson Fistel to learn more about the investigation and yo...

FTK Investor Alert: Johnson Fistel Encourages Flotek Industries, Inc. Investors to Contact the Firm Ahead of October 26, 2026 Lead Plaintiff Deadline

SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP, a shareholder-rights law firm, announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Flotek Industries, Inc. (NYSE: FTK) securities between August 3, 2026 and August 17, 2026, inclusive (the “Class Period”).The lawsuit, captioned Bashir v. Flotek Industries, Inc., et al., No. 1:26-cv-07285, is pending in the United States District Court for the Southern District of New York. The...
Back to Newsroom